# Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational

> **NCT05039723** · PHASE4 · COMPLETED · sponsor: **Main Line Center for Laser Surgery** · enrollment: 22 (actual)

## Conditions studied

- Photoaging

## Interventions

- **DRUG:** Radiesse, Xeomin, Belotero

## Key facts

- **NCT ID:** NCT05039723
- **Lead sponsor:** Main Line Center for Laser Surgery
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05039723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05039723, "Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05039723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*